The CardiAMP Heart Failure II Trial is a study to help people with heart failure caused by reduced blood flow to the heart. The study is testing a special treatment called CardiAMP cell therapy, which uses a patient's own bone marrow cells to improve heart health. Bone marrow is a soft tissue inside bones that makes blood cells. In this trial, doctors will compare this treatment to a regular heart procedure called diagnostic catheterization, which is a test to see how well the heart is working.
People in the trial will be divided into two groups: one group will get the CardiAMP therapy, and the other group will get the standard procedure without the therapy. The trial aims to see if the CardiAMP therapy is safe and effective.
- The study is for people with certain types of heart failure who have been on stable treatment for at least 3 months.
- Participants will need to undergo procedures, and some risks are involved.
- This study is conducted across multiple centers, meaning it takes place in various locations.
How understandable was the trial content above?
Hard to understand
Easy to understand